PEPFAR's annual planning process is done either at the country (COP) or regional level (ROP).
PEPFAR's programs are implemented through implementing partners who apply for funding based on PEPFAR's published Requests for Applications.
Since 2010, PEPFAR COPs have grouped implementing partners according to an organizational type. We have retroactively applied these classifications to earlier years in the database as well.
Also called "Strategic Areas", these are general areas of HIV programming. Each program area has several corresponding budget codes.
Specific areas of HIV programming. Budget Codes are the lowest level of spending data available.
Expenditure Program Areas track general areas of PEPFAR expenditure.
Expenditure Sub-Program Areas track more specific PEPFAR expenditures.
Object classes provide highly specific ways that implementing partners are spending PEPFAR funds on programming.
Cross-cutting attributions are areas of PEPFAR programming that contribute across several program areas. They contain limited indicative information related to aspects such as human resources, health infrastructure, or key populations programming. However, they represent only a small proportion of the total funds that PEPFAR allocates through the COP process. Additionally, they have changed significantly over the years. As such, analysis and interpretation of these data should be approached carefully. Learn more
Beneficiary Expenditure data identify how PEPFAR programming is targeted at reaching different populations.
Sub-Beneficiary Expenditure data highlight more specific populations targeted for HIV prevention and treatment interventions.
PEPFAR sets targets using the Monitoring, Evaluation, and Reporting (MER) System - documentation for which can be found on PEPFAR's website at https://www.pepfar.gov/reports/guidance/. As with most data on this website, the targets here have been extracted from the COP documents. Targets are for the fiscal year following each COP year, such that selecting 2016 will access targets for FY2017. This feature is currently experimental and should be used for exploratory purposes only at present.
Years of mechanism: 2007 2008
Public Health Evaluation: This is a continuing activity from FY07.
Project Title: Evaluation of an Integrated HIV and Drug Abuse Prevention, Care and Treatment Pilot
Program for Nhi Xuan IDU Rehabilitation Center Residents and Releases, Ho Chi Minh City, Vietnam
Name of Local Co- Investigator: Ho Chi Minh City Provincial AIDS Committee (HCMC PAC)
Project Description:
This is an FY07 continuing activity with additional funding for FY08. Abt Associates will work with the
PEPFAR Team to conduct an evaluation of the PEPFAR-funded Integrated HIV and Drug Abuse
Prevention, Care and Treatment Pilot. PEPFAR provides technical assistance and resources to the Vietnam
government drug rehabilitation program to improve transitions to the community for people being released
from Nhi Xuan center in Ho Chi Minh City (HCMC) to target districts where comprehensive HIV and
substance abuse services are available. This project is the evaluation of the PEPFAR pilot program's
effectiveness including cost effectiveness.
Timeline:
FY08 = Year 2 of activity
Year started: First funded in FY07. TBD reprogrammed to prime partner, Abt Associates, who expects to
receive FY07 funds in September 2007.
Expected year of completion: 2009 using FY08 funds.
Funding:
Funds received to date: $250,000
Funds expended to date: $0
Funds requested to complete the study:
FY08: $150,000
Beyond FY08: $0
Describe funds leveraged/contributed from other sources:
The process data collected during routine service delivery across program areas will be collected using
PEPFAR funding to implementing partners HCMC PAC and Family Health International (FHI).
Status of Study:
The study has not begun. The pilot to be studied is PEPFAR technical assistance provided to a government
of Vietnam (GVN) programmatic activity. The final components of the pilot are just being implemented
together with the GVN program. The study methodologies for the evaluation are developed and data
collection will begin pending final approval and receipt of funds.
Lessons Learned:
The study was funded in FY07, but has not started.
Information Dissemination Plan:
All dissemination of findings and reports will be through the Vietnam PEPFAR PHE Working Group. Abt
Associates will present the results of the outcome evaluation, including the quantitative and qualitative data,
in annual reports to the PEPFAR team. All technical and implementing partners may also prepare
manuscripts for submission to peer-reviewed journals and present findings at professional conferences.
These presentations will be cleared through PEPFAR and headquarter agency review.
Planned FY08 Activities:
The PHE will get underway in October 2007. In 2008, many of the first year activities from the two-year plan
will still be underway and the second year activities will follow later in the year.
The two-year plan for this PHE follows.
Evaluation Question:
This evaluation will determine whether the Integrated HIV and Drug Abuse Prevention, Care and Treatment
Pilot achieves its objectives and is worthy of replication, taking into account outcomes, costs, and other
factors. The HIV epidemic in Vietnam is focused in most at-risk populations with injecting drug users (IDUs)
accounting for 60% of all current HIV infections. The pilot is an extremely important project with great
significance for HIV prevention, care and treatment and for the future of the whole system of drug
rehabilitation and community re-entry in Vietnam and elsewhere. In the current system with limited or no
transitional assistance, relapse and recidivism rates are extremely high and the heavy resource investment
may be seen as largely wasted. This intervention has a chance to change that picture. Because of the cost
and innovation of this transitional pilot in HCMC, it is critical that a well-designed evaluation be conducted to
determine whether the intervention achieves its objectives and is worthy of replication, taking into account
outcomes, costs, and other factors. Specifically, the evaluation will identify strengths, weaknesses, gaps
and overlap to inform future PEPFAR planning for providing technical and financial assistance to
rehabilitation center to community transition programs for IDUs.
Methodology:
The evaluation will be divided into two components: process evaluation and outcome evaluation.
The process evaluation component is designed mainly to indicate whether the program is being
implemented as planned and that the services are reaching the intended population. This component of the
evaluation may be able to collect some limited outcome data but it is primarily intended to provide program
implementers with information to assess how the interventions are working, the quantity and, to some
extent, the quality of the services being provided, and to identify challenges and problems areas and
potential strategies for addressing them. The process evaluation will collect information on services
provided in Nhi Xuan Center, post-release services in the community, and qualitative interviews with
program staff and service providers.
The outcome evaluation is designed to determine whether the program is successful in achieving its client-
Activity Narrative: level objectives. The desired outcomes include reduced relapse to drug use; improved social stability in
terms of employment, housing, and lack of criminal activity; reduced HIV risk behaviors; and low HIV
incidence among HIV-negative clients; and continued access to quality care and adherence to ART for HIV-
positive clients. In order to capture these data, it is necessary to collect longitudinal, client-level data. We
propose to study a cohort of clients being released to all target districts and to compare their outcomes with
a cohort of individuals being released to another district in HCMC that is not participating in the pilot
transitional program. A comparison district will be selected. The outcome evaluation will be designed in year
one with data collection to begin once the interventions are considered to have been fully implemented,
presumably in year two.
Population of Interest:
Routine service delivery data on all consenting clients participating in the Nhi Xuan transition pilot will be
extracted from hardcopy and electronic client and service registries for the process evaluation. Additional
data will be collected from all consenting service providers. Clients will fall into one of three categories; HIV-
negative, HIV-positive and not yet eligible for ART, and HIV-positive on ART.
We propose to enroll 400 clients serially in the outcome evaluation, with informed consent, until a quota of
100 per target district has been reached. These samples should also include proportional representation of
the three client categories. Concurrently, we will also enroll a comparison group of 100 individuals being
released from Nhi Xuan to the comparison district. The comparison group should also include a proportional
representation of the three client categories described above.
The proposed sample sizes will allow us to detect, at acceptable levels of precision, reasonable differences
between the intervention and comparison groups in the following measures at 6-, 12-, and 24-months post
release. Below we calculate a minimum detectable effect at 80 percent power for various outcome
measures. They assume just one period of follow-up data, with 100 people in each of the five districts. For
simplicity, we have assumed the four intervention districts are homogeneous. These are conservative, as
we will collect data at four points in time for each respondent. The proportions given are initial estimates,
many based upon our experience in Vietnam with the China-Vietnam cross-border project.
Budget Justification for Year 1 Budget (USD):
Salaries/ fringe benefits: $183,151
Equipment: $11,065
Supplies: $2,154
Travel: $24,234
Participant Incentives: $471
Laboratory Testing: $20,195
Other: $8,730
Total: $250,000
Budget Justification for Year 2 Budget (USD):
Salaries/ fringe benefits: $109,900
Equipment: $6,600
Supplies: $1,293
Travel: $14,550
Participant Incentives: $283
Laboratory Testing: $12,117
Other: $5,257
Total: $150,000
